A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer
Johannes Albertus Langendijk, Patricia Doornaert, Derek H. F. Rietveld et al. · Radiotherapy and Oncology · 2009
Cited by 202 works. doi:10.1016/j.radonc.2008.12.017
Authors
- Johannes Albertus Langendijk
- Patricia Doornaert
- Derek H. F. Rietveld
- Irma M. Verdonck‐de Leeuw
- Charles René Leemans
- Ben J. Slotman
References
- Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
- Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
- A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
- Silent aspiration following stroke
- Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
- Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer
- Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial
- Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?
- Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial
- Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients